Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 3
1977 1
1979 4
1980 1
1981 2
1982 4
1984 2
1985 1
1986 1
1987 1
1988 1
1989 1
1990 5
1991 2
1992 3
1993 1
1996 3
1999 2
2001 1
2002 3
2003 1
2008 2
2009 2
2011 2
2012 2
2013 2
2014 4
2016 3
2017 2
2021 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

58 results
Results by year
Filters applied: . Clear all
Page 1
Antibody-mediated depletion of CCR10+EphA3+ cells ameliorates fibrosis in IPF.
Hohmann MS, Habiel DM, Espindola MS, Huang G, Jones I, Narayanan R, Coelho AL, Oldham JM, Noth I, Ma SF, Kurkciyan A, McQualter JL, Carraro G, Stripp B, Chen P, Jiang D, Noble PW, Parks W, Woronicz J, Yarranton G, Murray LA, Hogaboam CM. Hohmann MS, et al. Among authors: yarranton g. JCI Insight. 2021 Jun 8;6(11):e141061. doi: 10.1172/jci.insight.141061. JCI Insight. 2021. PMID: 33945505 Free PMC article.
EphA3 as a target for antibody immunotherapy in acute lymphoblastic leukemia.
Charmsaz S, Al-Ejeh F, Yeadon TM, Miller KJ, Smith FM, Stringer BW, Moore AS, Lee FT, Cooper LT, Stylianou C, Yarranton GT, Woronicz J, Scott AM, Lackmann M, Boyd AW. Charmsaz S, et al. Among authors: yarranton gt. Leukemia. 2017 Aug;31(8):1779-1787. doi: 10.1038/leu.2016.371. Epub 2016 Dec 6. Leukemia. 2017. PMID: 27922598
Targeting EphA3 inhibits cancer growth by disrupting the tumor stromal microenvironment.
Vail ME, Murone C, Tan A, Hii L, Abebe D, Janes PW, Lee FT, Baer M, Palath V, Bebbington C, Yarranton G, Llerena C, Garic S, Abramson D, Cartwright G, Scott AM, Lackmann M. Vail ME, et al. Among authors: yarranton g. Cancer Res. 2014 Aug 15;74(16):4470-81. doi: 10.1158/0008-5472.CAN-14-0218. Cancer Res. 2014. PMID: 25125683 Free article.
Recovery of recombinant proteins from yeast.
King DJ, Walton F, Smith BW, Dunn M, Yarranton GT. King DJ, et al. Among authors: yarranton gt. Biochem Soc Trans. 1988 Dec;16(6):1083-6. doi: 10.1042/bst0161083. Biochem Soc Trans. 1988. PMID: 3066664 No abstract available.
GM-CSF-dependent pSTAT5 sensitivity is a feature with therapeutic potential in chronic myelomonocytic leukemia.
Padron E, Painter JS, Kunigal S, Mailloux AW, McGraw K, McDaniel JM, Kim E, Bebbington C, Baer M, Yarranton G, Lancet J, Komrokji RS, Abdel-Wahab O, List AF, Epling-Burnette PK. Padron E, et al. Among authors: yarranton g. Blood. 2013 Jun 20;121(25):5068-77. doi: 10.1182/blood-2012-10-460170. Epub 2013 Apr 30. Blood. 2013. PMID: 23632888 Free PMC article.
A high affinity recombinant antibody to the human EphA3 receptor with enhanced ADCC activity.
Tomasevic N, Luehrsen K, Baer M, Palath V, Martinez D, Williams J, Yi C, Sujatha-Bhaskar S, Lanke R, Leung J, Ching W, Lee A, Bai L, Yarranton G, Bebbington C. Tomasevic N, et al. Among authors: yarranton g. Growth Factors. 2014 Dec;32(6):223-35. doi: 10.3109/08977194.2014.984808. Epub 2014 Nov 21. Growth Factors. 2014. PMID: 25413948
58 results